000 | 01919 a2200577 4500 | ||
---|---|---|---|
005 | 20250515132222.0 | ||
264 | 0 | _c20081028 | |
008 | 200810s 0 0 eng d | ||
022 | _a1021-335X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLu, Shun | |
245 | 0 | 0 |
_aSynergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice. _h[electronic resource] |
260 |
_bOncology reports _cSep 2008 |
||
300 |
_a581-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xtherapeutic use |
650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
650 | 0 | 4 |
_aCollagen Type I _xblood |
650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImidazoles _xtherapeutic use |
650 | 0 | 4 | _aImmunoenzyme Techniques |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aPaclitaxel _xtherapeutic use |
650 | 0 | 4 |
_aPeptides _xblood |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
650 | 0 | 4 | _aZoledronic Acid |
650 | 0 | 4 |
_abcl-2-Associated X Protein _xmetabolism |
650 | 0 | 4 |
_abcl-X Protein _xmetabolism |
700 | 1 | _aZhang, Jie | |
700 | 1 | _aZhou, Zhen | |
700 | 1 | _aLiao, Mei-Lin | |
700 | 1 | _aHe, Wei-Zhong | |
700 | 1 | _aZhou, Xiao-Yan | |
700 | 1 | _aLi, Zi-Ming | |
700 | 1 | _aXiang, Jia-Qing | |
700 | 1 | _aWang, Jie-Jun | |
700 | 1 | _aChen, Hai-Quan | |
773 | 0 |
_tOncology reports _gvol. 20 _gno. 3 _gp. 581-7 |
|
999 |
_c18170017 _d18170017 |